Nurexone Launches Licensing Efforts For Exotherapy Platform menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
NurExone Biologic launches licensing efforts for its ExoTherapy platform for creating nanodrugs by loading therapeutic molecular cargo into exosomes. .
TerraVest Industries Inc. (T.TVK) hit a new 52-week high of $57.30 Thursday. TerraVest announces its results for the first quarter ended December 31, 2023. Net income for the quarter was $19,303 versus $13,086 for the prior comparable quarter. This represents .
Terravest At 52-Week Highs On News menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
TORONTO and HAIFA, Israel, Feb. 02, 2024 (GLOBE NEWSWIRE) NurExone Biologic Inc. NRX (FSE: J90) (NRX.V), known as "NurExone," is pleased to announce the…